Mounjaro will soon be available as a weight loss treatment on the NHS – here’s what that means for patients
By Zoe Edwards, Research Lead/Advanced Clinical Practitioner/Senior Research Fellow, University of Bradford
Jonathan Silcock, Associate Professor in Pharmacy Practice, University of Bradford
Liz Breen, Director of the Digital Health Enterprise Zone (DHEZ), University of Bradford, Professor of Health Service Operations, University of Bradford
The weight loss jab Mounjaro will soon be made available to nearly a quarter of a million NHS patients, according to proposals made by the National Institute for Health and Care Excellence (Nice). Previously, it was only available on the NHS for patients with diabetes.
Under Nice’s…
Read complete article
© The Conversation
-
Tuesday, October 8, 2024